Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2024-11-14 00:00:00 ET · period of report 2024-11-12 · accession 0001628280-24-047993 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-14 | 2024-11-12 | BLFS | Mathew Aby J. | EVP, CSO | S - Sale | $26.34 | -123 | 317.0K | -0.0% | -$3,240 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-12 | S | D | 123 | $26.34 | 317,046 | D | — | — | (F1) The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. |